Quantcast
Channel: Modern medicine - alemtuzumab
Browsing all 4 articles
Browse latest View live

FDA rejects MS drug

FDA has rejected alemtuzumab (Lemtrada, Genzyme, a Sanofi company) for the treatment of relapsing forms of multiple sclerosis. FDA has taken the position that Genzyme has not submitted evidence from...

View Article



FDA drug approvals-November 2014

FDA actions in brief Hydrocodone bitartrate (Hysingla ER, Purdue Pharma), an extended-release (ER) opioid analgesic was approved to treat pain severe enough to require daily, around-the-clock,...

View Article

New drug approved by FDA for the treatment of relapsing MS

FDA has approved alemtuzumab (Lemtrada, Genzyme, A Sanofi Company) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Alemtuzumab is administered by intravenous infusion...

View Article

Image may be NSFW.
Clik here to view.

Drugs in Perspective: Lemtrada (alemtuzumab)

Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system and can lead to significant disability. An estimated 2.3 million people worldwide have been diagnosed with...

View Article
Browsing all 4 articles
Browse latest View live




Latest Images